Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial

Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States

(2015) Allison M. Liddell et al.   ANNALS OF INTERNAL MEDICINE

Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease

(2015) Diana F. Florescu et al.   CLINICAL INFECTIOUS DISEASES

Clinical Features of Patients With Ebola Virus Disease in Sierra Leone

(2015) Enqiang Qin et al.   CLINICAL INFECTIOUS DISEASES

Clinical Predictors of Mortality in Patients With Ebola Virus Disease

(2015) M. Barry et al.   CLINICAL INFECTIOUS DISEASES

The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States

(2015) Colleen S. Kraft et al.   CLINICAL INFECTIOUS DISEASES

The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June–October 2014

(2015) Gabriel Fitzpatrick et al.   JOURNAL OF INFECTIOUS DISEASES

Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care

(2015) Timo Wolf et al.   LANCET

Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

(2015) Emily P. Thi et al.   NATURE

Ebola Virus Disease among Children in West Africa

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea

(2015) Elhadj Ibrahima Bah et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characterization of Clinical and Immunological Parameters During Ebola Virus Infection of Rhesus Macaques

(2015) Karen Martins et al.   VIRAL IMMUNOLOGY

Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease

(2015) Ben S. Cooper et al.   PLOS MEDICINE

Current concepts in the diagnosis and management of cytokine release syndrome

(2014) D. W. Lee et al.   BLOOD

Randomised controlled trials for Ebola: practical and ethical issues

(2014) Clement Adebamowo et al.   LANCET

Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone

(2014) John S. Schieffelin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ebola Virus Disease in West Africa — Clinical Manifestations and Management

(2014) Daniel S. Chertow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Animal models for Ebola and Marburg virus infections

(2013) Eri Nakayama et al.   Frontiers in Microbiology

Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever

(2011) Mark G. Kortepeter et al.   JOURNAL OF INFECTIOUS DISEASES

Comprehensive Panel of Real-Time TaqMan™ Polymerase Chain Reaction Assays for Detection and Absolute Quantification of Filoviruses, Arenaviruses, and New World Hantaviruses

(2010) Adrienne R. Trombley et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

(2010) Thomas W Geisbert et al.   LANCET

An exact method for analysis following a two-stage phase II cancer clinical trial

(2010) Gordana Jovic et al.   STATISTICS IN MEDICINE